Spain IVF (in-vitro fertilization) Market Overview, 2029

The Spain infertility treatment market is anticipated to exceed USD 1.2 Billion by 2029, reflecting its emergence as a hub for fertility treatments.

With a reputation for excellent success rates, a favourable legislative framework, and an advanced medical infrastructure, Spain has become a major player in the worldwide in vitro fertilisation (IVF) business. The nation has made a name for itself as a top fertility tourism destination, drawing medical professionals from all around Europe. This is mostly because of its extensive and patient-friendly legal system, which allows for the use of a variety of reproductive procedures that could be prohibited or subject to rigorous regulations in other nations. Spain's IVF industry is a centre for both conventional and cutting-edge fertility treatments thanks to its highly qualified medical personnel and state-of-the-art equipment. With a reputation for excellent success rates, a favourable legislative framework, and an advanced medical infrastructure, Spain has become a major player in the worldwide in vitro fertilisation (IVF) business. The nation has made a name for itself as a top fertility tourism destination, drawing medical professionals from all around Europe. This is mostly because of its extensive and patient-friendly legal system, which allows for the use of a variety of reproductive procedures that could be prohibited or subject to rigorous regulations in other nations. Spain's IVF industry is a centre for both conventional and cutting-edge fertility treatments thanks to its highly qualified medical personnel and state-of-the-art equipment Furthermore, Spain's advantageous geographic location and sophisticated transportation network. Besides, patients from other countries may easily go to Spain thanks to its advantageous geographic position and advanced transportation system. For people looking to have IVF treatments overseas, Spain is a desirable choice because to its accessibility and cheap cost, which is frequently less expensive than in the US and other Western European nations.Reproductive medicine research and development are likewise prominent in Spain, where a large number of clinical investigations and trials have advanced the subject. In order to ensure that patients receive the most recent medical research and technical advancements, academic institutions and fertility clinics work together to promote innovation.

According to the research report "Spain Infertility Treatment XXX Market Overview, 2029," published by Bonafide Research, the Spain Infertility Treatment market is expected to reach a market size of more than USD 1.2 Billion by 2029. Spain has become a popular location for in vitro fertilisation (IVF) procedures in recent years, thanks to a number of significant advancements that have shaped the industry. One notable development is the nation's patient-accessible and innovatively-friendly regulatory framework for assisted reproductive technologies, which is supported by progressive legislation. Modern facilities and specialised knowledge are provided by Spain's well-known fertility clinics, which are drawing more and more local and foreign patients seeking reproductive therapies. IVF procedures have also been improved as a result of continuous research endeavours. For example, preimplantation genetic testing has been used to improve embryo selection and increase success rates. Collaborations among academic institutions, medical professionals, and business leaders propel IVF technology and patient care forward and establish Spain as a world leader in infertility treatments.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The world of in vitro fertilisation (IVF) cycles in Spain is made up of several kinds, each with unique traits and methods. The intended parents provide both the egg and the sperm in a new non-donor IVF round. In this cycle, several eggs are produced by ovarian stimulation and then collected and fertilised in a lab environment. Before embryos are placed into the uterus, they are cultivated for a few days. With no need for freezing, this kind of cycle has the benefit of instant therapy, which may increase certain patients' chances of success. Using previously frozen embryos produced during a fresh round or by cryopreservation of excess embryos is the method used in a frozen non-donor IVF cycle. This technique lessens the requirement for ovarian stimulation and gives schedule flexibility. Patients who have completed preimplantation genetic testing (PGT) or who must postpone embryo transfer for medical reasons frequently like it since it gives time for test results to be retrieved. Frozen embryos derived from a donor egg and sperm are inserted into the recipient's uterus during an IVF cycle using frozen donors. Couples who are having trouble becoming pregnant because of low-quality eggs or other reasons frequently select this course of action. Frozen donor embryos can speed up therapy and drastically cut down on waiting times, giving hope to patients who would not be successful using their own gametes. The eggs and sperm used in a fresh donor IVF cycle are usually from anonymous donors. When a person or couple is unable to conceive using their own gametes, they frequently choose this alternative. New donor cycles provide the chance for a more customised match between donors and recipients, which may increase the likelihood of success and increase the level of emotional fulfilment. The eggs and sperm used in a fresh donor IVF cycle are usually from anonymous donors. When a person or couple is unable to conceive using their own gametes, they frequently choose this alternative. New donor cycles provide the chance for a more customised match between donors and recipients, which may increase the likelihood of success and increase the level of emotional fulfilment.
Over time, there has been a rise in the use and regulation of assisted reproductive technologies in Spain. These methods include donor egg IVF, IVF with ICSI (Intracytoplasmic Sperm Injection), standard IVF, and other variants. The main kind of assisted reproduction is called conventional IVF, which entails stimulating the ovaries to create numerous eggs, extracting them, and fertilising them with sperm in a lab dish. In Spain, fertility clinics have perfected and standardised this approach, providing hope to infertile couples. When a single sperm is inserted directly into the egg to accomplish fertilisation, the IVF with ICSI procedure is very helpful for male infertility. Due to the revolutionary nature of this procedure, conception is now possible in situations of severe male factor infertility. Another option offered in Spain is IVF using donor eggs, which offers a route to motherhood for couples who are having problems with the quality or quantity of their eggs. Women who are unable to generate viable eggs on their own might find relief through donor eggs, which are usually obtained from young, healthy donors. Also, these traditional approaches, Spain's reproductive clinics could provide other cutting-edge procedures customised for each patient. These might include methods to increase the rate of embryo implantation, including endometrial receptivity analysis (ERA), or preimplantation genetic testing (PGT) to check embryos for genetic problems. Alternatively, embryos could be frozen for later use.

Fertility clinics, hospitals, surgery centres, cryobanks, and research institutions are just a few of the many and ever-changing medical facilities in Spain that support reproductive health and research. Fertility clinics are essential for helping single people and couples on their path to becoming parents. From basic fertility screenings to cutting-edge reproductive procedures like intrauterine insemination (IUI) and in vitro fertilisation (IVF), these clinics provide a wide variety of treatments. Due to its sophisticated medical facilities and welcoming legal system, Spain is a well-liked location for fertility tourism. As such, these clinics cater not just to Spanish citizens but also to international patients in search of top-notch reproductive therapies The need for the services provided by fertility clinics is increasing due to improvements in assisted reproductive technology (ART) and increased public knowledge of fertility treatments. Modern facilities and highly qualified medical staff enable Spain's hospitals and surgical centres to offer a wide range of reproductive healthcare treatments. These clinics provide a broad range of care, including surgical procedures for disorders including endometriosis and uterine fibroids that impair fertility. They also act as essential hubs for handling complicated situations and offering patients receiving reproductive operations or treatments integrated care. In Spain, cryobanks are essential for the preservation and storage of reproductive organs and cells, such as eggs, sperm, and embryos. Strict regulatory requirements are followed by these facilities to guarantee their viability and safety. These facilities provide individuals and couples choices for assisted reproduction, family planning, and fertility preservation while adhering to stringent regulatory criteria to guarantee the safety and viability of stored specimens. By providing biological resources for investigations intended to further our knowledge of reproductive biology and enhance fertility therapies, cryobanks also contribute to medical research. Reproductive biology and medicine research institutions provide substantial contributions to the field's innovation and knowledge growth. These cutting-edge research projects in Spain are focused on solving problems related to reproductive health, creating novel therapies for infertility, and deciphering the intricacies of human reproduction. By working in tandem with academic institutions, healthcare facilities, and business associates, these research centres significantly contribute to advancement and the development of reproductive healthcare in Spain and worldwide.



Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• IVF market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By cycle
• Fresh Non-donor IVF Cycle
• Frozen Non-donor IVF Cycle
• Frozen donor IVF Cycle
• Fresh donor IVF Cycle

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval


By Conventional IVF
• Conventional IVF
• IVF with ICSI (Instracytoplasmic Sperm Injection)
• IVF With Donor Eggs
• other

By End user
• Fertility Clinics
• Hospital & Surgical Centers
• Cryobanks
• Research institute

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

Table of Contents

  • 1. Executive Summary
  • 2. Market Structure
  • 2.1. Market Considerate
  • 2.2. Assumptions
  • 2.3. Limitations
  • 2.4. Abbreviations
  • 2.5. Sources
  • 2.6. Definitions
  • 2.7. Geography
  • 3. Research Methodology
  • 3.1. Secondary Research
  • 3.2. Primary Data Collection
  • 3.3. Market Formation & Validation
  • 3.4. Report Writing, Quality Check & Delivery
  • 4. Spain Macro Economic Indicators
  • 5. Market Dynamics
  • 5.1. Market Drivers & Opportunities
  • 5.2. Market Restraints & Challenges
  • 5.3. Market Trends
  • 5.3.1. XXXX
  • 5.3.2. XXXX
  • 5.3.3. XXXX
  • 5.3.4. XXXX
  • 5.3.5. XXXX
  • 5.4. Covid-19 Effect
  • 5.5. Supply chain Analysis
  • 5.6. Policy & Regulatory Framework
  • 5.7. Industry Experts Views
  • 6. Spain Infertility Treatment Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Size and Forecast, By cycle
  • 6.3. Market Size and Forecast, By Conentional IVF
  • 6.4. Market Size and Forecast, By End user
  • 7. Spain Infertility Treatment Market Segmentations
  • 7.1. Spain Infertility Treatment Market, By cycle
  • 7.1.1. Spain Infertility Treatment Market Size, By Fresh Non-donor IVF Cycle, 2018-2029
  • 7.1.2. Spain Infertility Treatment Market Size, By Frozen Non-donor IVF Cycle, 2018-2029
  • 7.1.3. Spain Infertility Treatment Market Size, By Frozen donor IVF Cycle, 2018-2029
  • 7.1.4. Spain Infertility Treatment Market Size, By Fresh donor IVF Cycle, 2018-2029
  • 7.2. Spain Infertility Treatment Market, By Conentional IVF
  • 7.2.1. Spain Infertility Treatment Market Size, By Conentional IVF, 2018-2029
  • 7.2.2. Spain Infertility Treatment Market Size, By IVF with ICSI (Instracytoplasmic Sperm Injection), 2018-2029
  • 7.2.3. Spain Infertility Treatment Market Size, By IVF with Donor Eggs, 2018-2029
  • 7.2.4. Spain Infertility Treatment Market Size, By other, 2018-2029
  • 7.3. Spain Infertility Treatment Market, By End user
  • 7.3.1. Spain Infertility Treatment Market Size, By Fertility Clinics, 2018-2029
  • 7.3.2. Spain Infertility Treatment Market Size, By Hospital & Surgical Centers, 2018-2029
  • 7.3.3. Spain Infertility Treatment Market Size, By Cryobanks, 2018-2029
  • 7.3.4. Spain Infertility Treatment Market Size, By Research institute, 2018-2029
  • 8. Spain Infertility Treatment Market Opportunity Assessment
  • 8.1. By cycle, 2024 to 2029
  • 8.2. By Conentional IVF, 2024 to 2029
  • 8.3. By End user, 2024 to 2029
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profile
  • 9.2.1. Company 1
  • 9.2.1.1. Company Snapshot
  • 9.2.1.2. Company Overview
  • 9.2.1.3. Financial Highlights
  • 9.2.1.4. Geographic Insights
  • 9.2.1.5. Business Segment & Performance
  • 9.2.1.6. Product Portfolio
  • 9.2.1.7. Key Executives
  • 9.2.1.8. Strategic Moves & Developments
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer

Table 1: Influencing Factors for Infertility Treatment Market, 2023
Table 2: Spain Infertility Treatment Market Size and Forecast, By cycle (2018 to 2029F) (In USD Million)
Table 3: Spain Infertility Treatment Market Size and Forecast, By Conentional IVF (2018 to 2029F) (In USD Million)
Table 4: Spain Infertility Treatment Market Size and Forecast, By End user (2018 to 2029F) (In USD Million)
Table 5: Spain Infertility Treatment Market Size of Fresh Non-donor IVF Cycle (2018 to 2029) in USD Million
Table 6: Spain Infertility Treatment Market Size of Frozen Non-donor IVF Cycle (2018 to 2029) in USD Million
Table 7: Spain Infertility Treatment Market Size of Frozen donor IVF Cycle (2018 to 2029) in USD Million
Table 8: Spain Infertility Treatment Market Size of Fresh donor IVF Cycle (2018 to 2029) in USD Million
Table 9: Spain Infertility Treatment Market Size of Conentional IVF (2018 to 2029) in USD Million
Table 10: Spain Infertility Treatment Market Size of IVF with ICSI (Instracytoplasmic Sperm Injection) (2018 to 2029) in USD Million
Table 11: Spain Infertility Treatment Market Size of IVF With Donor Eggs (2018 to 2029) in USD Million
Table 12: Spain Infertility Treatment Market Size of other (2018 to 2029) in USD Million
Table 13: Spain Infertility Treatment Market Size of Fertility Clinics (2018 to 2029) in USD Million
Table 14: Spain Infertility Treatment Market Size of Hospital & Surgical Centers (2018 to 2029) in USD Million
Table 15: Spain Infertility Treatment Market Size of Cryobanks (2018 to 2029) in USD Million
Table 16: Spain Infertility Treatment Market Size of Research institute (2018 to 2029) in USD Million

Figure 1: Spain Infertility Treatment Market Size By Value (2018, 2023 & 2029F) (in USD Million)
Figure 2: Market Attractiveness Index, By cycle
Figure 3: Market Attractiveness Index, By Conentional IVF
Figure 4: Market Attractiveness Index, By End user
Figure 5: Porter's Five Forces of Spain Infertility Treatment Market
Logo

Spain IVF (in-vitro fertilization) Market Overview, 2029

Contact usWe are friendly and approachable, give us a call.